TSX:AEZS - Post Discussion
Post by
prophetoffactz on Jul 08, 2024 11:12am
Top-line diagnostic results
AEZS's pediatric clinical trial completed its last patient last visit 25 days ago with top-line results expected in Q3 2024. AEZS's adult clinical trial was completed 2016-11-29 according to clinicaltrials.gov: Study Details | Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency | ClinicalTrials.gov Top-line results for the adult trial were reported 36 days later in a news release: 2017-01-04 | Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™ | TSX:AEZS | Press Release (stockhouse.com) The 36 days to report the top-line adult clinical trial results may have been complicated by Christmas and New Year's holidays. Assuming it takes 30-36 days to report the pediatric top-line results, given that it has been 25 days since the last patient last visit, it may be possible that we see the top-line results for the pediatric trial next week. That puts it potentially right around the time of the AGM which is on July 16, 2024.
Be the first to comment on this post